Merdad Parsey - Nov 10, 2022 Form 4 Insider Report for GILEAD SCIENCES, INC. (GILD)

Role
Chief Medical Officer
Signature
/s/ Amy Kim by Power of Attorney for Merdad Parsey
Stock symbol
GILD
Transactions as of
Nov 10, 2022
Transactions value $
-$187,337
Form type
4
Date filed
11/14/2022, 11:42 AM
Previous filing
Sep 12, 2022
Next filing
Dec 13, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GILD Common Stock Options Exercise +5.1K +11.93% 47.8K Nov 10, 2022 Direct F1
transaction GILD Common Stock Tax liability -$187K -2.27K -4.74% $82.60 45.6K Nov 10, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GILD Restricted Stock Unit Options Exercise -5.1K -10.15% 45.1K Nov 10, 2022 Common Stock 5.1K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
F2 The restricted stock units have a three year vesting schedule. 33.33% will vest on each yearly anniversary of the date of grant until fully vested.